Exact Sciences
EXAS
EXAS was delisted on the 20th of March, 2026.
129 hedge funds and large institutions have $750M invested in Exact Sciences in 2013 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 57 increasing their positions, 31 reducing their positions, and 16 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
84% more repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 31
56% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 16
7% more funds holding
Funds holding: 121 → 129 (+8)
5.85% more ownership
Funds ownership: 83.74% → 89.59% (+5.9%)
9% less capital invested
Capital invested by funds: $824M → $750M (-$73.6M)
19% less call options, than puts
Call options by funds: $18.5M | Put options by funds: $22.8M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Trust Advisors
Wheaton,
Illinois
|
+$35.7M |
| 2 |
CCI
Columbus Circle Investors
|
+$16.5M |
| 3 |
6CM
683 Capital Management
New York
|
+$12.1M |
| 4 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$11M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$10.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$12.2M |
| 2 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$11M |
| 3 |
D.E. Shaw & Co
New York
|
-$8.92M |
| 4 |
PC
Pier Capital
Stamford,
Connecticut
|
-$8.85M |
| 5 |
DCM
Decade Capital Management
New York
|
-$8.17M |
EXAS Hedge Fund Activity: Q3 2013 in Review
129 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q3 2013, worth a combined $750M — down 8.9% from $824M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new EXAS positions and 16 closed out — a net gain of 9 holders — while 57 added to existing stakes and 31 trimmed.
The largest buyer was First Trust Advisors, opening a new position worth an estimated $35.7M. The largest seller was JP Morgan Chase, cutting an estimated $12.2M.
- 129 institutional investors held Exact Sciences (EXAS) as of Q3 2013, up from 121 in Q2 2013.
- Funds reported $750M of Exact Sciences stock for Q3 2013, down 8.9% quarter-over-quarter.
- 25 funds opened new Exact Sciences positions in Q3 2013 and 16 closed out, a net change of +9 holders.
- The largest Exact Sciences buyer in Q3 2013 was First Trust Advisors, an estimated $35.7M added.
- The largest Exact Sciences seller in Q3 2013 was JP Morgan Chase, an estimated $12.2M sold.
Based on aggregated 13F filings for Q3 2013.